investpharma ltd Company Information
Company Number
08105746
Next Accounts
Mar 2026
Industry
Other personal service activities n.e.c.
Directors
Shareholders
oleg movcean
viorica reschitor
View AllGroup Structure
View All
Contact
Registered Address
5 brayford square, stepney green, london, E1 0SG
Website
-investpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of INVESTPHARMA LTD at £0 based on a Turnover of £0 and 0.73x industry multiple (adjusted for size and gross margin).
investpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of INVESTPHARMA LTD at £0 based on an EBITDA of £-6 and a 4.29x industry multiple (adjusted for size and gross margin).
investpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of INVESTPHARMA LTD at £0 based on Net Assets of £-5.1k and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Investpharma Ltd Overview
Investpharma Ltd is a live company located in london, E1 0SG with a Companies House number of 08105746. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in June 2012, it's largest shareholder is oleg movcean with a 49% stake. Investpharma Ltd is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Investpharma Ltd Health Check
There is insufficient data available to calculate a health check for Investpharma Ltd. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Investpharma Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Investpharma Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Investpharma Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (47 weeks)
- - Investpharma Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 108.1%, this is a higher level of debt than the average (42.7%)
- - Investpharma Ltd
- - Industry AVG
INVESTPHARMA LTD financials
Investpharma Ltd's latest turnover from June 2024 is estimated at 0 and the company has net assets of -£5.1 thousand. According to their latest financial statements, we estimate that Investpharma Ltd has no employees and maintains cash reserves of £122 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | ||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 63,486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 63,486 | 63,486 | 63,486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 63,486 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 122 | 122 | 122 | 0 | 122 | 122 | 122 | 122 | 122 | 122 | 100 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 122 | 122 | 122 | 122 | 122 | 122 | 122 | 122 | 122 | 122 | 100 | 0 |
total assets | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 63,608 | 100 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 66,904 | 0 | 0 | 0 | 0 | 64,871 | 64,871 | 750 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 68,749 | 68,749 | 68,749 | 0 | 65,278 | 64,871 | 64,871 | 64,871 | 0 | 0 | 0 | 0 |
total current liabilities | 68,749 | 68,749 | 68,749 | 66,904 | 65,278 | 64,871 | 64,871 | 64,871 | 64,871 | 64,871 | 750 | 0 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 68,749 | 68,749 | 68,749 | 66,904 | 65,278 | 64,871 | 64,871 | 64,871 | 64,871 | 64,871 | 750 | 0 |
net assets | -5,141 | -5,141 | -5,141 | -3,296 | -1,670 | -1,263 | -1,263 | -1,263 | -1,263 | -1,263 | -650 | 0 |
total shareholders funds | -5,141 | -5,141 | -5,141 | -3,296 | -1,670 | -1,263 | -1,263 | -1,263 | -1,263 | -1,263 | -650 | 0 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | ||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | -122 | 122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | -66,904 | 66,904 | 0 | 0 | 0 | -64,871 | 0 | 64,121 | 750 | 0 |
Accruals and Deferred Income | 0 | 0 | 68,749 | -65,278 | 407 | 0 | 0 | 64,871 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | 0 | 0 | 0 | -63,486 | 0 | 0 | 0 | 0 | 0 | 63,486 | 0 | 0 |
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | 0 | 0 | 122 | -122 | 0 | 0 | 0 | 0 | 0 | 22 | 100 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 122 | -122 | 0 | 0 | 0 | 0 | 0 | 22 | 100 | 0 |
investpharma ltd Credit Report and Business Information
Investpharma Ltd Competitor Analysis
Perform a competitor analysis for investpharma ltd by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other established companies, companies in E 1 area or any other competitors across 12 key performance metrics.
investpharma ltd Ownership
INVESTPHARMA LTD group structure
Investpharma Ltd has no subsidiary companies.
Ultimate parent company
INVESTPHARMA LTD
08105746
investpharma ltd directors
Investpharma Ltd currently has 1 director, Ms Juliette Clarisse serving since Jan 2022.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Juliette Clarisse | United Kingdom | 46 years | Jan 2022 | - | Director |
P&L
June 2024turnover
0
0%
operating profit
-6.4
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
-5.1k
0%
total assets
63.6k
0%
cash
122
0%
net assets
Total assets minus all liabilities
investpharma ltd company details
company number
08105746
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
June 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
-
address
5 brayford square, stepney green, london, E1 0SG
Bank
-
Legal Advisor
-
investpharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to investpharma ltd.
investpharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INVESTPHARMA LTD. This can take several minutes, an email will notify you when this has completed.
investpharma ltd Companies House Filings - See Documents
date | description | view/download |
---|